Ticker
JAGXCompany Name
JAGUAR HEALTH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -27.68M | -234.34% | $ 11.81M |
3/31/2025 | $ -29.65M | -256.69% | $ 11.55M |
12/31/2024 | $ -29.38M | -251.38% | $ 11.69M |
9/30/2024 | $ -29.01M | -276.8% | $ 10.48M |
6/30/2024 | $ -29.46M | -289.23% | $ 10.19M |
3/31/2024 | $ -30.34M | -299.25% | $ 10.14M |
12/31/2023 | $ -33.24M | -340.56% | $ 9.76M |
9/30/2023 | $ -32.21M | -300.48% | $ 10.72M |
6/30/2023 | $ -33.95M | -307.04% | $ 11.06M |
3/31/2023 | $ -35.35M | -312.78% | $ 11.3M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for JAGUAR HEALTH INC is calculated as follows: CF - Operations [ $ -14.36M ] / Revenues [ $ 8.32M ]
(=) OCF % [ -172.63% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |